#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune myositis Conjunctivitis allergic Transitional cell carcinoma Breast angiosarcoma Juvenile chronic myelomonocytic leukaemia Alexander disease Hypereosinophilic syndrome Non-small cell lung cancer metastatic Orthostatic hypotension Aplastic anaemia Mucopolysaccharidosis I PIK3CA related overgrowth spectrum Marginal zone lymphoma refractory Metastatic malignant melanoma Heavy menstrual bleeding More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung Metachromatic leukodystrophy – Trials in Disease Idiopathic pulmonary fibrosis Turner’s syndrome – Treatment Osteosarcoma recurrent – Basic Information Hereditary angioedema – Trials in Disease Sjogren’s syndrome – Life with Disease Mastocytosis – Trials in Disease Ornithine transcarbamoylase deficiency – Treatment Glycogen storage disease type II – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ruxotemitide Tramadol Hydrochloride MARALIXIBAT Bisacodyl Iloprost Trometamol Glucose Monohydrate Ph. Eur. Dalbavancin Chlorhexidine Gluconate Amy109 Sunvozertinib Relugolix Acoramidis Mitomycin TROFOLASTAT Magnesium Hydroxide ACETYLCARNITINE HYDROCHLORIDE Linerixibat Durvalumab Eteplirsen Vildagliptin More therapies…

    Learn about Your Condition

    Hepatorenal syndrome Immunosuppression Thalassaemia alpha Seizure Demyelination Leiomyosarcoma Mitral valve prolapse Myotonia Encephalitis Japanese B Myasthenia gravis Multifocal motor neuropathy Naevoid melanoma Habitual abortion Thymoma malignant Phenylketonuria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Cd152
    • Docetaxel
    Belgium Germany Italy Spain

  • Study on Iron Infusion with Ferric Carboxymaltose for Elderly Patients with Severe Aortic Stenosis and Iron Deficiency Undergoing TAVI

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic stenosis
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    The Netherlands

  • Study of NMS-03305293 and Temozolomide for Adults with Recurrent Glioblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Nms-03305293
    • Temozolomide
    Italy The Netherlands

  • Study of Dasatinib for Patients with Acute Myeloid Leukemia Not Responding to Venetoclax-Azacitidine Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Dasatinib
    France

  • Study on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Rbl005.3
    • Rbl007.2
    • Rbl012.2
    Germany Poland Spain

  • Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ivonescimab
    • Carboplatin
    • Paclitaxel
    France Germany Greece Ireland Italy Poland +1
Previous Page
1 … 885 886 887 888 889 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!